![Igor Koralnik](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Igor Koralnik
Corporate Officer/Principal bei Oxeia Biopharmaceuticals, Inc.
Aktive Positionen von Igor Koralnik
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Oxeia Biopharmaceuticals, Inc.
![]() Oxeia Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Oxeia Biopharmaceuticals, Inc. is a clinical-stage biotech company, which develops new, innovative therapies for conditions that are defined by deficits in neurocognition from injury, degeneration and aging. Its two indications are for (i) mild traumatic brain injury (?mTB?) known as concussion, and (ii) the cognitive decline, lethargy and ?brain-fog? associated with Covid-19 infection, known as Covid Longhauler syndrome (?Long Covid?). The company was founded in 2014 by Vishal Bansal, Amit Dilip Munshi & Kartik Kiran Shah and is headquartered in Boston, MA. | Corporate Officer/Principal | - | - |
Karriereverlauf von Igor Koralnik
Statistik
International
Vereinigte Staaten | 2 |
Operativ
Corporate Officer/Principal | 1 |
Sektoral
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Oxeia Biopharmaceuticals, Inc.
![]() Oxeia Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Oxeia Biopharmaceuticals, Inc. is a clinical-stage biotech company, which develops new, innovative therapies for conditions that are defined by deficits in neurocognition from injury, degeneration and aging. Its two indications are for (i) mild traumatic brain injury (?mTB?) known as concussion, and (ii) the cognitive decline, lethargy and ?brain-fog? associated with Covid-19 infection, known as Covid Longhauler syndrome (?Long Covid?). The company was founded in 2014 by Vishal Bansal, Amit Dilip Munshi & Kartik Kiran Shah and is headquartered in Boston, MA. | Health Technology |
- Börse
- Insiders
- Igor Koralnik
- Erfahrung